Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LuMIERE: 177Lu-FAP-2286 in Advanced Solid Tumors
NCT04939610Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Jul 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of AAA614 in solid tumor, pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), breast cancer, sponsored by Novartis. Started Jul 2021; status: recruiting.
02
Drugs
AAA614
03
Conditions
solid tumorpancreatic ductal adenocarcinoma (PDAC)non-small cell lung cancer (NSCLC)breast cancer
Beyond the preview
Go deeper on NCT04939610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04939610.